Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
Clinical trial NCT04882124 · COMPLETED
Trial details
- NCT number
- NCT04882124
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2022-09-15
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.